Medical weight loss is not a diet plan — it's a diagnosis. Dr. Sanjay Sachdev evaluates the underlying picture (insulin resistance, thyroid, PCOS, sleep, medications), then combines lifestyle changes with medical therapy when appropriate — including supervised GLP-1 (Ozempic, Wegovy, Mounjaro) for eligible patients.
BMI ≥27 with a health condition (diabetes, prediabetes, fatty liver, high BP, sleep apnoea) or BMI ≥30 without one — the standard thresholds. Under a doctor's care, expected loss is 10–15% of body weight over 6–12 months, with real improvement in sugar, BP and cholesterol.
First visit: full metabolic panel, weight/waist/BMI, medication review, screening for reversible causes. Plan: nutrition, sleep, structured activity — with GLP-1 added only when clinically appropriate. Follow-up every 4–8 weeks to adjust dose, watch side effects, and prevent muscle loss.
Not every weight concern needs a prescription. The right consult depends on the underlying picture — this is how the practice sorts it.
Book a full medical weight-management consult. GLP-1 candidacy is assessed on labs, not weight alone.
Metabolic-first plan — often metformin + lifestyle before GLP-1 is considered.
Usually a structured lifestyle plan, not medication. Book a nutrition-focused consult.
Do NOT chase weight-loss drugs — this needs a diagnostic workup for thyroid, diabetes, GI causes and infection.
C-58, Friends Colony East, New Delhi 110065
Closest to: Friends Colony, NFC, Sukhdev Vihar, Okhla
Maharani Bagh Community Centre, 1 Maharani Bagh, New Delhi 110065
Closest to: Maharani Bagh, Nizamuddin, Jangpura, Sunder Nagar
Approximate drive times from common South & South-East Delhi neighbourhoods.
Tap a question to expand · 6 answers
The standard threshold is BMI ≥27 with a weight-related condition, or BMI ≥30 without one. Not for cosmetic weight loss.
With supervised GLP-1 plus lifestyle changes, 10–15% of body weight over 12 months is realistic.
Yes, when supervised. Muscle-mass preservation, side-effect management and structured tapering are what make it safe.
Mild nausea, early fullness and occasional constipation, especially in the first 4–6 weeks. A slow dose titration and hydration usually settle it.
No — the goal is a supervised course of 9–18 months alongside lifestyle change, then a structured taper. Regain risk is managed by continued lifestyle work.
HbA1c, fasting insulin, thyroid, lipid, LFT, kidney function and vitamin D. Any gaps are corrected before starting.
Share your pincode and symptoms — the clinic will route you to the nearest clinic and earliest slot.